stockportfolio.pro
Harmony Biosciences Holdings, Inc. Free Cash Flow 2019–2025
Harmony Biosciences Holdings, Inc. (HRMY) annual free cash flow by fiscal year, computed from SEC filings.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $347.89M | +59.1% |
| FY 2024 | $218.67M | -0.2% |
| FY 2023 | $219.07M | +51.8% |
| FY 2022 | $144.29M | +46.9% |
| FY 2021 | $98.26M | +3389.6% |
| FY 2020 | $-2.99M | +96.0% |
| FY 2019 | $-75.58M | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s free cash flow?
Harmony Biosciences Holdings, Inc. (HRMY) reported free cash flow of $347.89M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.